The New Darlings Of The Anti-Aging Industry & The Russian’s Secret Age Reversal Weapon: Peptide Bioregulators With Phil Micans.

29 Jan 2026 · 78 min
Episode

29 Jan 2026 · 78 min

0:00

Podcast interview (Ben Greenfield with Phil Micans) about peptide bioregulators — very short (2–4 amino-acid) peptides researched extensively in Russia (Prof. Vladimir Kavinson) that act as organ-specific epigenetic gene-switches and 'bioregulators' to up- or down-regulate tissue-specific gene expression. Key topics covered: history (Soviet military/cosmonaut origins), mechanism (nano-sized peptides interact with DNA as gene switches without altering sequence), examples (pineal peptide Epitalon/Epitalamine, thymus peptides, vascular peptide, and others), scope (commercially ~21 bioregulators; combinations emerging), large human trials (Gazprom: ~11,000 workers with 8,000 on peptides vs 3,000 controls with 1–12 year follow-ups showing ~1/3 morbidity and mortality in peptide group), clinician experience (Dr. Bill Lawrence reports telomere lengthening and reversal of DNA methylation age in patients), oral bioactivity (capsules effective though injections more potent), safety/scale (Russians report >1M people treated and ~100M capsules consumed with no reported side effects), practical protocols (many users take 2 capsules/day for 10 days, cycled quarterly; common core: pineal, vascular, thymus; occasional detox month adds liver/kidney/pancreas), and related products (Can-C N-acetylcarnosine eye drops reported to reduce/remove cataracts in ~80–89% with 2 drops twice daily for ~5–6 months). Episode includes multiple sponsor ad reads and references to resources (Aging Matters magazine, books by Phil Micans, Bill Lawrence clinical summaries).

Questions this episode answers

21

About 11,000 employees total: ~8,000 received peptides and ~3,000 were controls (vitamin capsules); follow-ups at 1 year, smaller cohorts at 6 years and 12 years.

Reportedly about one third the morbidity and one third the mortality compared with controls in the peptide group.

Epitalon (also called Epitalamine in some contexts).

Can‑C (Can see) eyedrops containing N‑acetylcarnosine; dosing cited: two drops twice daily for roughly 5–6 months, with reported cataract reduction/removal in about 80–89% of trial participants.

Chapters

More from Eric

55:46
Podcast

Season 2 | Episode 86 | Technology, AI, and What it Means to Be Human with John Dyer, Ph.D.

3d ago
1:00:27
Podcast

Season 2 | Episode 85 | Kamusta ka? -- Cultural diversity in therapy, athletic performance, and all things RT with Marriage and Family Therapy Associate, Kim Agramon-Bai

1w ago
1:03:28
Podcast

Season 2 | Episode 84 | Noe Rivera, RT Therapist & Director of Relate Strong at Pepperdine

2w ago
1:03:17
Podcast

Season 2 | Episode 83 | Associate Marriage and Family Therapist Sammy Chaves

2w ago
59:16
Podcast

Season 2 | Episode 82 | Gil and Brenda Stuart's Journey to RT and Development of Their Book, Lilly's Pads

3w ago
1:09:43
Podcast

Season 2 | Episode 81 | RT, trains and The Little Engine that Could with Therapist Mary Lee Evans

1mo ago
1:08:06
Podcast

Season 2 | Episode 80 | Therapeutic Models and Training Students with Lipscomb Professor Dave Morgan

2mo ago
1:07:55
Podcast

Season 2 | Episode 79 | Trauma, Emotional Regulation and Learning RT, with Kaivon Asgharian

2mo ago
54:11
Podcast

Season 2 | Episode 78 | Spiritual Abuse & Recovery with RT Therapist Nathan Ely

3mo ago
1:16:01
Podcast

Season 2 | Episode 77 | Special Guest, RT Therapist Amanda Tipps

3mo ago
44:33
Podcast

Season 2 | Episode 76 | What we typically do in a first session

3mo ago
See all content